The management of upper airway diseases: an ongoing challenge for the clinician

G. Ciprandi, D. Passali

Article ID: 5532
Vol 35, Issue 1S2, 2021
DOI: https://doi.org/10.23812/21-1supp2-1
Received: 11 March 2021; Accepted: 11 March 2021; Available online: 11 March 2021; Issue release: 11 March 2021

Abstract

Upper airway diseases are widespread in clinical practice. However, some aspects are still debated. The current supplement presents and discusses the most common disorders encountered in daily medical activity. The COVID-19 dramatic pandemic requires an urgent solution. Promising non-pharmacological agents are discussed. Chronic diseases are frequent in childhood, so to know risk factors is useful in their management. Allergic rhinitis and chronic rhinosinusitis should be treated with anti-inflammatory drugs, but complementary compounds should be alternated to preserve health. Empty nose syndrome is a frequent complication of nasal surgery and requires adequate staging and hydrating procedure. Lastly, laryngopharyngeal reflux is an intriguing challenge for the clinician. Alginates represent a safe and effective way to relieve LPR symptoms.


Keywords

upper airways diseases;COVID-19;allergic rhinitis;chronic rhinosinusitis;empty nose syndrome;laryngopharyngeal reflux


References

Supporting Agencies



Copyright (c) 2021 G. Ciprandi, D. Passali




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).